Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Governments worldwide are using digital contact tracing (DCT) apps as a critical element in their COVID-19 pandemic lockdown exit strategy. Despite substantial investment in research and development, the public's acceptance of DCT apps has been phenomenally low, signaling resistance among potential users. Little is known about why people would resist using the DCT app, a useful innovation that can potentially save millions of human lives. This study explores the determinants and consequences of citizens' resistance to use DCT apps using a sequential two-stage mixed-methods approach. The preliminary qualitative study analyzed interviews of 24 Indian smartphone users who chose not to use or discontinued the DCT app after an initial trial. In the quantitative stage, an integrated model based on innovation resistance theory and distrust theory was tested using the survey data collected from 194 non-adopters of the DCT app from India. The findings revealed that the factors, distrust, value barrier, information privacy concerns, and usage barrier predicted the resistance to the DCT app, and resistance, in turn, predicted intention to use. Additionally, distrust was found to be a key mediator between innovation barriers and resistance. The insights from this study could help the developers and policymakers formulate strategies for implementing DCT interventions during future disease outbreaks.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755900 | PMC |
| http://dx.doi.org/10.1016/j.ijinfomgt.2021.102468 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment of digital therapeutics in decentralized clinical trials: A scoping review.
PLOS Digit Health
June 2025
Department of Rheumatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
This scoping review aims to identify the necessary and practical considerations for the design, conduct and safety of decentralized clinical trials (DCTs) that test digital therapeutics (DTx) or software as a medical device (SaMD). The review follows the framework of Arksey & O'Malley. A search strategy with the keywords "Digital therapeutics" or "Software as Medical Device" AND "decentralized clinical trial" or synonyms was applied to Cochrane CENTRAL, EMBASE, MEDLINE and Web of Science databases with the latest search on the 25th of April 2025.
View Article and Find Full Text PDFMitigating fraud in a fully decentralized clinical trial of a digital health intervention.
Ann Behav Med
January 2025
Stanford Prevention Research Center, Department of Medicine, School of Medicine, Stanford University, Palo Alto, CA, USA.
Background: Decentralized clinical trials (DCT), digital survey methodologies, and health monitoring technologies create the potential to reduce study participant burden as well as enhance sample diversity and enrollment pace. However, fraudulent participant activity poses a significant threat to study validity and data integrity.
Purpose: This study quantifies fraudulent attempts at participation in a DCT of a mobile mental health intervention for problematic substance use and discusses methods to prevent and detect fraudulent activity.
Effects of User Experience in Automated Information Processing on Perceived Usefulness of Digital Contact-Tracing Apps: Cross-Sectional Survey Study.
JMIR Hum Factors
June 2024
Institute for Multimedia and Interactive Systems, Universität zu Lübeck, Lübeck, Germany.
Background: In pandemic situations, digital contact tracing (DCT) can be an effective way to assess one's risk of infection and inform others in case of infection. DCT apps can support the information gathering and analysis processes of users aiming to trace contacts. However, users' use intention and use of DCT information may depend on the perceived benefits of contact tracing.
View Article and Find Full Text PDFAn evaluation of the COVID-19 self-service digital contact tracing system in New Zealand.
Health Policy
June 2024
Department of Public Health, University of Otago, Wellington, New Zealand.
Background: Digital contact tracing (DCT) aims to improve time-to-isolation (timeliness) and find more potentially exposed individuals (sensitivity) to enhance the utility of contact tracing. The aim of this study was to evaluate the public uptake of a DCT self-service survey and its integration with the Bluetooth exposure notification system within the New Zealand Covid Tracer App (NZCTA).
Methods: We adopted a retrospective cohort study design using community COVID-19 cases from February 2022 to August 2022 in New Zealand (1.
Population and contact tracer uptake of New Zealand's QR-code-based digital contact tracing app for COVID-19.
Epidemiol Infect
April 2024
Department of Public Health, University of Otago, Wellington, New Zealand.
Article Synopsis
- The study analyzed the effectiveness and usage of the QR-code feature in the New Zealand COVID Tracer App (NZCTA) among COVID-19 cases from August 2020 to February 2022.
- It found that Asian and other ethnicities were significantly more likely to use the QR code feature compared to Māori during both the Delta and Omicron periods, with variations depending on the organization handling the cases.
- The QR code system had a low effectiveness for identifying close contacts but was very effective in identifying casual contacts, indicating its limited impact on controlling the spread of COVID-19 in New Zealand.